Downs Christopher 4
4 · CNS Pharmaceuticals, Inc. · Filed Apr 18, 2023
Insider Transaction Report
Form 4
Downs Christopher
Chief Financial Officer
Transactions
- Purchase
Common Stock
2023-04-17$3.20/sh+3,100$9,920→ 9,251 total
4 · CNS Pharmaceuticals, Inc. · Filed Apr 18, 2023
Common Stock